Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Conclusions: This study confirms prior evidence for rhabdomyolysis associations with daptomycin, macrolides, trimethoprim-sulfamethoxazole, linezolid, fluoroquinolones, and cefdinir. This study also identifies previously unknown rhabdomyolysis associations with meropenem, cefditoren, cefaclor, and piperacillin-tazobactam.
PMID: 31673242 [PubMed - in process]
Source: International Journal of Medical Sciences - Category: Biomedical Science Tags: Int J Med Sci Source Type: research
More News: Azithromycin | Bactrim | Biaxin | Biomedical Science | Cipro | Ciprofloxacin | Clarithromycin | Cubicin | Erythromycin | Linezolid | Rhabdomyolysis | Statistics | Study | Sulfamethoxazole | Trimethoprim | Zithromax | Zyvox